Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Nanobiotechnology, Artificial Intelligence, and Virtual Care

May 6, 2021 | AI, COVID-19, Digital Transformation, Impetus Digital, Nanowear, Natalie Yeadon, Venk Varadan, artificial intelligence, chronic diseases, congestive heart failure, deep learning, diagnostics, nanosensor technology, nanotechnology, remote monitoring 

Venk Varadan, Co-founder & CEO at Nanowear, explores the use of cloth-based nanosensor technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and COVID-19. We also dive into digital transformation in healthcare and Venk shares his predictions for the future of nanotechnology.

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their...

Top 10 Most Important Advisor Questions

Impetus Digital shares its Top 10 list of the most important advisor questions.

Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story

Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.

Courageous Conversations ep.4: Five Key Benefits of the Internet of Medical Things

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Courageous Conversations ep.2: What Our Healthcare System Can Learn from AlphaGo

Courageous Conversations ep.1: Why Our Healthcare System is in Dire Need of Disruption